Navigation Links
Pall launches new products to increase supply of safe blood
Date:10/22/2007

that ten percent additional plasma than traditional whole-blood collection systems. The alternative option is to process some of the donated blood into non-leukocyte reduced platelets, a conventional amount of plasma as well as red cells. In this case, the non-leukoreduced platelets can then also be processed with the Acrodose PLus to make an Acrodose Platelet.

Demand for blood components can change daily, sometimes hourly, depending upon circumstances or emergencies. Both plasma and platelets are precious blood components and are becoming increasingly more valuable with the institution of new restrictions on the donor pool to reduce potentially fatal diseases such as TRALI (transfusion-related acute lung injury). Additionally, platelets whose main function is to aid in clotting have a very short life span (5 to 7 days prior to being discarded). Plasma is the liquid portion of blood which transports blood cells, water and nutrients to the bodys tissues and also contains many proteins that help the blood to clot and fight disease.


'/>"/>

Contact: Marcia Katz
Marcia_Katz@pall.com
516-801-9851
Pall Corporation
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Glaxo launches pills to help smokers quit in 7-12 weeks
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. Dr Reddy’s Laboratories launches Hyalosy
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. Scottish Health Minister Launches Organ Donor Plan
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
8. Pfizer Launches Viagra For Lung Disease In UK
9. PM Launches Healthcare Foundation For India
10. African Union Launches A Programme On Acceleration of HIV Prevention
11. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...ach doctors-in-training how to do ultrasound-guide...skills without compromising patient care and safet...al. , The study shows that this simulation-based... medical residents, knowledge, dexterity and confi...sound-guided procedures, including breast biopsies...
(Date:11/29/2009)...der boosts urine production, experts say , ...ho wake up during the night to urinate shouldn,t a...ea, a breathing-related sleep disorder, could be t... urination, or nocturia, is comparable to loud sno...sorder in which soft tissue in the throat blocks t...
(Date:11/28/2009)... consider change after 30-minute psychosocial inte...7 (HealthDay News) -- A program that gets persiste...their dangerous behavior may lead to significant a..., The new study included 184 men and women with ...o were randomly assigned to one of two interventio...
(Date:11/27/2009)...rm Replikins Ltd. today issued its latest biochemi...hows that the lethality of the virus has dropped f...current outbreak in the spring of 2009 to resting ...he H1N1 infectivity count, however, remains increa...ember 27, 2009 -- Biotech firm Replikins Ltd., whi...
(Date:11/27/2009)...ov. 27 Shamir Optical In...ng provider of innovative products and technology ...t its board of directors had declared a dividend d...on (approximately NIS 37.62 million based on the N... or approximately US$ 0.609 (approximately NIS 2.3...
Breaking Medicine News(10 mins):Health News:Simulated training for ultrasound-guided procedures improves safety without risk to patients 2Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3
... has backed down from his earlier stand and has sa...e and not compulsory. // "We are planning to...couple to go for the HIV/AIDS tests before marriag...DS is linked to the tourism." he added that the to...
...erdeen in the UK say in a new study that low mater...sk of asthma in kids//. The study is a continuatio...t low vitamin E in mothers was linked to increased...a, persistent wheeze, wheezing or asthma during th...
... reduce the amount of sugar (glucose) in the blood....// Type 2 diabetes occurs when people canno...properly. Insulin is the essential hormone that he...he disease is mainly confined to people over the a...
...Carolina Wilmington announce the continuation of f... tide brevetoxins and ultimately// yield treatment...Sciences awarded UNCW the five-year $7.53 million ... "Preliminary studies with red tide toxin have ...
...rmed in Wisconsin, the outbreak of the disease is ...e person has succumbed to the disease in the state...ases have needed hospital admission and four of th... places affected are Green Lake counties and Outag...
...s shrink and new infectious agents threaten blood ...t outcomes by implementing// transfusion alternati...s? These questions, and the positive steps that ca...Annual National Meeting in Jersey City, New Jersey...
Other Medicine News:Health News:"Beach to Bedside" Study Focuses on Effects of Inhaled Toxins 2
(Date:11/27/2009)... CITY, Nov. 27 Booth - 3...YSE: VAR ), a premier supplier of X-ray tubes an... its full range of detectors at the RSNA Annual Me... 3, 2009. Varian will also be exhibiting X-ray tu...pecialized cancer treatment technologies. ,, V...
(Date:11/26/2009)...BURG, South Africa, Nov. 26 The 20...e Year Award in the Generic Pharmaceutical Market ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh...ar Award, the following criteria were used to benc...titors: growth strategy and implementation, degree...
(Date:11/25/2009)... Colo., Nov. 25 Heska Co...f advanced diagnostic and specialty products to ...s with Roche Diagnostics Corporation for the suppl... for the veterinary market. ,, (Logo: http... ) ,, "Heska and Roche share the same passion f...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Pelosi Statement on Release of Draft Health Reform Outline 48382 1 22Alliance between Europe Cosmetiques and Probiox brings new oxydative stress profiling technologies to North America 22 48378 1 22Alliance between Europe Cosmetiques and Probiox brings new oxydative stress profiling technologies to North America 22 48378 2Bioniche Pharma and Synerx Pharma Launch Melphalan Hydrochloride for Injection 48373 1Bioniche Pharma and Synerx Pharma Launch Melphalan Hydrochloride for Injection 48373 2
...e 3 data, from BLISS-52 trial, expected by mid-200...xpected by fall 2009 -, ROCKVILLE, Md., Aug. 27 ... announced it has completed enrollment,and initial...se 3,randomized clinical trials of LymphoStat-B(R)...s erythematosus (SLE). Belimumab is being develope...
..., Aug. 26 Semafore Pharmaceuticals Inc.,presented...geted Therapies,in Cancer in Washington, D.C., ann...se inhibitors that demonstrate significant antican... proprietary molecular scaffold has been developed...ign of pan-PI3 kinase inhibitors,as well as isofor...
Other Medicine Technology:Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3
...er is designed for fast & easy operation. The 5.7 ...for everyone., ,In AUTO mode, the readings are...ned. Multi-Focal lenses are automatically detected...rrectly position the lens. The color touch panel d...
Pro-lll
FF 450plus Fundus Camera
TRC-50FXC
Medicine Products: